Asiyeh Pormehr-Yabandeh

Asiyeh Pormehr-Yabandeh

Auto-generated profile, based on publicly available information

Asiyeh Pormehr-Yabandeh

Hormozgan Health Institute Hormozgan University of Medical Science Bandar Abbas Iran

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2019 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
MBMojdeh Banaei
Mojdeh Banaei
MAMaryam Azizi
Maryam Azizi
AMAzam Moridi
Azam Moridi
SDSareh Dashti
Sareh Dashti
AYAsiyeh Pormehr Yabandeh
Asiyeh Pormehr Yabandeh
NRNasibeh Roozbeh
Nasibeh Roozbeh
Sexual dysfunction refers to a chain of psychiatric, individual, and couple’s experiences that manifests itself as a dysfunction in sexual desire, sexual arousal, orgasm, and pain during intercourse. The aim of this systematic review will be to assess the sexual dysfunction and determine the relevant factors to sexual dysfunction during pregnancy and postpartum. All observational studies, including descriptive, descriptive-analytic, case-control, and cohort studies published between 1990 and 2019, will be included in the study. Review articles, case studies, case reports, letter to editors, pilot studies, and editorial will be excluded from the study. The search will be conducted in the Cochrane Central Register, MEDLINE, Google Scholar, EMBASE, ProQuest, Scopus, WOS, and CINAHL databases. Eligible studies should assess at least one of the sexual dysfunction symptoms in pregnant women or in the first year postpartum. Quality assessment of studies will be performed by two authors independently based on the NOS checklist. This checklist is designed to assess the quality of observational studies. Data will be analyzed using Stata software ver. 11. Considering that the index investigated in the present study will be the level of sexual disorder, standard error will be calculated for each study using binomial distribution. The heterogeneity level will be investigated using Cochran’s Q statistic and I2 index in a chi-square test at a significance level of 1.1. Predictable limitations of this study included a small number and unacceptable quality of studies. This systematic review addresses the factors associated with sexual dysfunction during pregnancy and postpartum. Considering the high prevalence of sexual dysfunction among women, the treatment of this problem has been highly sought after by the World Health Organization in recent years. The results of this study can help discover new strategies by introducing factors affecting women’s sexual dysfunction, thereby eliminating or diminishing these factors, and play an important role in improving the quality of life of women during pregnancy and postpartum periods. PROSPERO CRD42018083554

17 July 2014 in Oman Medical Journal
Verified
Journal Article
Open access
FDFatemeh Dabiri
Fatemeh Dabiri
AYAsieh Pormehr Yabandeh
Asieh Pormehr Yabandeh
ASArefeh Shahi
Arefeh Shahi
AKAzita Kamjoo
Azita Kamjoo
STSaeed Hosseini Teshnizi
Saeed Hosseini Teshnizi
To evaluate the effect of mode of delivery on postpartum sexual functioning in primiparous women. In this cross-sectional descriptive study, 150 primiparous women in postpartum period, who attended the family planning or vaccination clinics, were enrolled for the study. Eighty-one had vaginal delivery with episiotomy and 69 had experienced cesarean section. Sexual function was evaluated by the Female Sexual Function Index within 3 and 6 months postpartum. About 29% in vaginal delivery group and 37% in cesarean delivery group had resumed their sexual intercourses four weeks after delivery (p=0.280).There were no significant differences between mode of delivery and sexual functioning, including desire, arousal, lubrication, orgasm, satisfaction and pain. The present study showed that postpartum sexual functioning was not associated with the type of delivery.

1 July 2018 in International Journal of Women's Health and Reproduction Sciences
Verified
Journal Article
Closed access
PDF file
SASedigheh Amir Aliakbari
Sedigheh Amir Aliakbari
SSSanaz Safarzadeh
Sanaz Safarzadeh
FBFatemeh Bayat
Fatemeh Bayat
APAsiyeh Pormehr-Yabandeh
Asiyeh Pormehr-Yabandeh
SDSareh Dashti
Sareh Dashti
MBMojdeh Banaei
Mojdeh Banaei

20 March 2023 in Current Molecular Medicine
Verified
Journal Article
Closed access
PDF file
NDNiloofar Deravi
Niloofar Deravi
ARAsma Rasouli
Asma Rasouli
NZNasibeh Zerangian
Nasibeh Zerangian
MHMehrnoush Baradaran Hezave
Mehrnoush Baradaran Hezave
AAAva Aghakhani
Ava Aghakhani
NTNeda Tizro
Neda Tizro
Flavonoids are classified into subclasses of polyphenols, a multipurpose category of natural compounds which comprises secondary metabolites extracted from vascular plants and are plentiful in the human diet. Although the details of flavonoid mechanisms are still not realized correctly, they are generally regarded as anti-microbial, anti-fungal, anti-inflammatory, anti-oxidative; anti-mutagenic; anti-neoplastic; anti-aging; anti-diabetic, cardio-protective, etc. The anti-cancer; properties of flavonoids are evident in functions such as prevention of proliferation, metastasis, invasion, inflammation and activation; of cell death. Tumors growth and enlargement expose cells to acidosis, hypoxia, and lack of nutrients which result in endoplasmic reticulum (ER) stress; it triggers the unfolded protein response (UPR), which reclaims homeostasis or activates autophagy. Steady stimulation of ER stress can switch autophagy to apoptosis. The connection between ER stress and cancer, in association with UPR, has been explained. The signals provided by UPR can activate or inhibit anti-apoptotic or apoptotic pathways depending on the period and grade of ER stress. In this review, we will peruse the link between flavonoids and their impact on the endoplasmic reticulum in association with cancer therapy.

10 April 2025 in Health Science Reports
Verified
Journal Article
Open access
AVAli Vaezi
Ali Vaezi
SRSeyyed Kiarash Sadat Rafiei
Seyyed Kiarash Sadat Rafiei
BABita Amiri
Bita Amiri
ARAli Rezvanimehr
Ali Rezvanimehr
MAMaryam Naji Abhary
Maryam Naji Abhary
NDNiloofar Deravi
Niloofar Deravi
Background and Aims: Venous thromboembolism (VTE) is a distinct malignancy complication that raises the risk of demise in cancer patients by up to thrice. However, pregnant females have a 4–5 times greater chance of getting VTE than nonpregnant women. The current systematic review aimed to elucidate the impact of malignancy on the risk of VTE in pregnant females.Methods: We carried out a systematic search in multiple databases, including PubMed (Medline), Google Scholar, and Scopus, up to January 2023. Finally, 441 related articles were extracted from the databases. After screening the title, abstract, and full text, seven articles were included in the study.Results: Seven studies (six cohorts and one cross‐sectional) with 58,854,195 pregnant females (22,396 cancer patients) were included. These studies were done in the United States of America, Canada, Brazil, and Denmark. All of the studies except one study demonstrated that cancer in pregnant patients increased the risk of deep vein thrombosis (DVT). The risk of VTE prevalence in pregnant females with a record of malignancy was significantly higher than in free cancer groups, and the highest aOR was correlated to myeloid leukemia.Conclusions: Evidence in this systematic review showed that pregnant women with malignancy are more susceptible to VTE and other coagulation disorders. Physicians and health policymakers should be of high vigilance to pregnancy‐associated VTE, especially in women who have cancer.

2 October 2019 in Shiraz E-Medical Journal
Verified
Journal Article
Open access
PDF file
AMAzam Moridi
Azam Moridi
MBMojdeh Banaei
Mojdeh Banaei
SDSareh Dashti
Sareh Dashti
NSNasim Shahrahmani
Nasim Shahrahmani
APAsiyeh Pormehr-Yabandeh
Asiyeh Pormehr-Yabandeh
Implementation of the health reform plan in health centers is offered by health care providers where the quality of services is important as they deal with ...